American Association for Cancer Research

Table 5

Multivariate analysis of survival of individual parameters in ovarian adenocarcinoma patients

Factors	RR^a	95% CI^b	P
Age (<50 yrs vs. >51 yrs)	1.304	0.637–2.669	0.4683
Clinical stage (stage I vs. stage II/III/IV)	10.395	3.487–30.989	<0.0001
Histologic grade (grade I vs. grade 2/3)	1.686	0.912–3.119	0.0957
Skp2 expression (negative or partial vs. diffuse)^c	2.736	1.317–5.680	0.0069

Factors	RR^a	95% CI^b	P
Age (<50 yrs vs. >51 yrs)	1.304	0.637–2.669	0.4683
Clinical stage (stage I vs. stage II/III/IV)	10.395	3.487–30.989	<0.0001
Histologic grade (grade I vs. grade 2/3)	1.686	0.912–3.119	0.0957
Skp2 expression (negative or partial vs. diffuse)^c	2.736	1.317–5.680	0.0069

RR, risk ratio.

CI, confidence interval.

Skp2 expression was categorized as negative, partial positive vs. diffuse positive.